Moreover, persistent ERK1/2 activation in colon cancer cells was associated with the following: i) enhanced TF binding to the proximal promoter region of genes associated with invasion, ii) transcriptional up-regulation of invasion-related genes, and iii) corresponding increase in invasive activity. The gene discussed is MAPK3; the disease is malignant colon neoplasm.